Logo image of WOK

WORK MEDICAL TECHNOLOGY GR-A (WOK) Stock Fundamental Analysis

NASDAQ:WOK - Nasdaq - KYG9767H1092 - Common Stock - Currency: USD

0.7752  0 (-0.23%)

Fundamental Rating

1

Overall WOK gets a fundamental rating of 1 out of 10. We evaluated WOK against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of WOK have multiple concerns. WOK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

WOK had positive earnings in the past year.
In the past year WOK has reported a negative cash flow from operations.
WOK Yearly Net Income VS EBIT VS OCF VS FCFWOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

WOK's Return On Assets of 0.31% is fine compared to the rest of the industry. WOK outperforms 73.26% of its industry peers.
With a decent Return On Equity value of 0.85%, WOK is doing good in the industry, outperforming 73.26% of the companies in the same industry.
WOK's Return On Invested Capital of 1.11% is fine compared to the rest of the industry. WOK outperforms 67.91% of its industry peers.
Industry RankSector Rank
ROA 0.31%
ROE 0.85%
ROIC 1.11%
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WOK Yearly ROA, ROE, ROICWOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

WOK's Profit Margin of 0.83% is fine compared to the rest of the industry. WOK outperforms 73.80% of its industry peers.
With a decent Operating Margin value of 3.04%, WOK is doing good in the industry, outperforming 67.91% of the companies in the same industry.
WOK has a Gross Margin of 30.54%. This is in the lower half of the industry: WOK underperforms 74.87% of its industry peers.
WOK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
WOK Yearly Profit, Operating, Gross MarginsWOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), WOK is destroying value.
Compared to 1 year ago, WOK has more shares outstanding
The debt/assets ratio for WOK is higher compared to a year ago.
WOK Yearly Shares OutstandingWOK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M
WOK Yearly Total Debt VS Total AssetsWOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 1.85 indicates that WOK is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of WOK (1.85) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.01 is on the high side and indicates that WOK has dependencies on debt financing.
WOK's Debt to Equity ratio of 1.01 is on the low side compared to the rest of the industry. WOK is outperformed by 78.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z 1.85
ROIC/WACC0.16
WACC6.88%
WOK Yearly LT Debt VS Equity VS FCFWOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

WOK has a Current Ratio of 1.03. This is a normal value and indicates that WOK is financially healthy and should not expect problems in meeting its short term obligations.
WOK has a Current ratio of 1.03. This is amonst the worse of the industry: WOK underperforms 89.30% of its industry peers.
A Quick Ratio of 0.87 indicates that WOK may have some problems paying its short term obligations.
WOK's Quick ratio of 0.87 is on the low side compared to the rest of the industry. WOK is outperformed by 83.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.87
WOK Yearly Current Assets VS Current LiabilitesWOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for WOK have decreased strongly by -3670.13% in the last year.
Looking at the last year, WOK shows a very negative growth in Revenue. The Revenue has decreased by -15.18% in the last year.
Measured over the past years, WOK shows a very negative growth in Revenue. The Revenue has been decreasing by -36.93% on average per year.
EPS 1Y (TTM)-3670.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.96%
Revenue 1Y (TTM)-15.18%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-63.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOK Yearly Revenue VS EstimatesWOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 77.52 indicates a quite expensive valuation of WOK.
Compared to the rest of the industry, the Price/Earnings ratio of WOK indicates a somewhat cheap valuation: WOK is cheaper than 64.71% of the companies listed in the same industry.
WOK is valuated expensively when we compare the Price/Earnings ratio to 26.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 77.52
Fwd PE N/A
WOK Price Earnings VS Forward Price EarningsWOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, WOK is valued a bit cheaper than the industry average as 74.87% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.5
WOK Per share dataWOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WOK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WORK MEDICAL TECHNOLOGY GR-A

NASDAQ:WOK (8/1/2025, 8:11:07 PM)

0.7752

0 (-0.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.6%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap43.82M
AnalystsN/A
Price TargetN/A
Short Float %3.08%
Short Ratio0.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 77.52
Fwd PE N/A
P/S 3.23
P/FCF N/A
P/OCF N/A
P/B 3.32
P/tB 3.61
EV/EBITDA 20.5
EPS(TTM)0.01
EY1.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.24
BVpS0.23
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.31%
ROE 0.85%
ROCE 2.57%
ROIC 1.11%
ROICexc 1.43%
ROICexgc 1.49%
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
FCFM N/A
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 7.31
Cap/Depr 656.39%
Cap/Sales 68.25%
Interest Coverage 0.76
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.87
Altman-Z 1.85
F-Score3
WACC6.88%
ROIC/WACC0.16
Cap/Depr(3y)251.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)31.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3670.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.18%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-63.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1081.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-806.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-200.83%
OCF growth 3YN/A
OCF growth 5YN/A